Results 61 to 70 of about 2,705 (182)
Typhoid conjugate vaccine (TCV) coverage estimates among children of different age groups in selected union councils of Lyari Town, Karachi.
, 2023 Typhoid conjugate vaccine (TCV) coverage estimates among children of different age groups in selected union councils of Lyari Town, Karachi.Sonia Qureshi (6940871), Rehana A. Salam (8098277), Tahira Sadaf (16792862), Zoya Haq (11140940), Mohammad Tahir Yousafzai (8982443), Farah Naz Qamar (6940889), Rabab Batool (16792856), Rafey Ali (16792859), Miqdad Ali (16792865) +8 morecore +1 more sourceEvaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics
Vaccines, 2021 Typhoid fever remains a significant health problem in sub-Saharan Africa, with incidence rates of >100 cases per 100,000 person-years of observation. Despite the prequalification of safe and effective typhoid conjugate vaccines (TCV), some uncertainties ...Andrea Haekyung Haselbeck, Birkneh Tilahun Tadesse, Juyeon Park, Malick M. Gibani, Ligia María Cruz Espinoza, Ariane Abreu, Craig Van Rensburg, Michael Owusu-Ansah, Sampson Twuamsi-Ankrah, Michael Owusu, Isaac Aguna, Valentina Picot, Hyonjin Jeon, Ellen Higginson, Sunju Park, Zenaida R. Mojares, Justin Im, Megan E. Carey, Farhana Khanam, Susan Tonks, Gordon Dougan, Deokryun Kim, Jonathan Sugimoto, Vittal Mogasale, Kathleen M. Neuzil, Firdausi Qadri, Yaw Adu-Sarkodie, Ellis Owusu-Dabo, John Clemens, Florian Marks +29 moredoaj +1 more sourceOne-month evaluation of safety and immunogenicity of a Vi-DT typhoid conjugate vaccine (Bio-TCV®) in Indonesian subjects 6 months to 45 years: A phase III randomized clinical trial
Vaccine: XBackground: Typhoid fever typically affects children and young adults and is a considerable cause of morbidity and mortality. Vaccination is the most effective preventive strategy to control typhoid fever in the short to medium term.Bernie Endyarni Medise, I. Gusti Ayu Trisna Windiani, Dominicus Husada, Rini Sekartini, Hartono Gunardi, Angga Wirahmadi, Dwiyanti Puspitasari, Leny Kartina, I. Gusti Agung Ngurah Sugitha Adnyana, I. Gusti Lanang Sidiartha, I. Made Dwi Lingga Utama, I. Ketut Agus Somia, Iris Rengganis, Sukamto Koesnoe, Hindra Irawan Satari, Soedjatmiko Soedjatmiko, Sri Rezeki Hadinegoro, Ismoedijanto Ismoedijanto, Parwati Setiono Basuki, Gatot Soegiarto, Soetjiningsih Soetjiningsih, Rini Mulia Sari, Mita Puspita, Aria Kekalih, Sreshta Mukhi, Vianca Samara Andhary, Novilia Sjafri Bachtiar, Sushant Sahastrabuddhe +27 moredoaj +1 more sourcePopulation structure of Salmonella enterica Typhi in Harare, Zimbabwe (2012-19) before typhoid conjugate vaccine roll-out: a genomic epidemiology study. [PDF]
Lancet Microbe, 2023 Background: The continued emergence of Salmonella enterica serovar Typhi, with ever increasing antimicrobial resistance, necessitates the use of vaccines in endemic countries.Thilliez G, Mashe T, Chaibva BV, Robertson V, Bawn M, Tarupiwa A, Takawira FT, Kock MM, Midzi S, Mwamakamba LW, Matheu J, Juru A, Kingsley RA, Ehlers MM. +13 moreeuropepmc +2 more sourcesPhase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol
BMJ OpenIntroduction Enteric fever, primarily caused by Salmonella enterica Typhi and Salmonella enterica Paratyphi A (SPA), is endemic mainly in South Asia, disproportionately affecting school-age children.Elizabeth Jones, Xinxue Liu, Andrew J Pollard, Brian Angus, Parvinder Aley, Eleanor Wilson, Hannah Robinson, Amy Flaxman, Prasad S Kulkarni, Nisha Singh, Naina McCann, Young Chan Kim, Margarete Paganotti Vicentine, Oisin Hennigan, Noshi Maria, Claudia I Juarez Molina, Stanislava Koleva, Mohammod K Islam, Nicole Day, Allison MacDonald, Mehreen Adnan, Sophie Vernon, Anirudha Vyankatesh Potey, Abhijeet Dharmadhikari, Sanket Gaidhane, Maheshi Nirmala Ramasamy +25 moredoaj +1 more sourceThe Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK [PDF]
, 2017 Typhoid fever is estimated to cause between 11.9–26.9 million infections globally each year with 129,000–216,510 deaths. Access to improved water sources have reduced disease incidence in parts of the world but the use of efficacious vaccines is seen as ...Bradford D. Gessner, Meiring, James, Levine, MM, Zaidi, Anita, Neuzil, K, Gordon, Melita A, Mohan, V.K., Pollard, Andrew J, Pitzer, VE, David Salisbury, Darton, Thomas, Pitzer, Virginia E, Karen L. Kotloff, Neuzil, K., Basnyat, B, Kotloff, KL, Marfin, Anthony A, Date, K., Kotloff, K.L., Malick Gibani, Mulholland, K, Darton, TC, Garrett, D., Anthony A. Marfin, Pollard, AJ, Gibani, M., Denise Garrett, Qadri, F., John Clemens, Vadrevu Krishna Mohan, Mohan, VK, Joachim Hombach, Zaidi, A., Levine, Myron M, Adwoa D. Bentsi-Enchill, Buddha Basnyat, Basnyat, Buddha, Heyderman, R.S., Dougan, Gordon, Meiring, JE, Salisbury, D, Pitzer, V.E., Hombach, J, Heyderman, RS, Salisbury, David, Marfin, AA, Darton, Thomas C, Myron M. Levine, Kathleen Neuzil, Bentsi-Enchill, Adwoa D, Date, Kashmira, Qadri, Firdausi, Gessner, Bradford D, Meiring, James E, Qadri, F, Robert S. Heyderman, Stephen P. Luby, Mohan, Vadrevu Krishna, Luby, S.P., Luby, SP, Hombach, Joachim, Mulholland, Kim, Gibani, M, Zaidi, A, Gessner, B.D., Gordon Dougan, Bentsi-Enchill, A.D., Firdausi Qadri, Garrett, Denise, Kashmira Date, Kotloff, Karen L, Group, T.C.M., Meiring, J.E., Neuzil, Kathleen, Pollard, Andrew, Virginia E. Pitzer, Heyderman, Robert S, Dougan, G., Basnyat, B., Darton, T.C., Levine, M.M., Clemens, J, Bentsi-Enchill, Adwoa, Garrett, D, Luby, Stephen P, Marfin, A.A., Ty, VCMG, Clemens, J., Hombach, J., Andrew J. Pollard, Gessner, BD, Clemens, John, Thomas C. Darton, James E. Meiring, Anita Zaidi, Melita A. Gordon, Mulholland, K., Gordon, MA, TyVAC Consortium Meeting Group, ., Pollard, A.J., Gordon, M.A., Bentsi-Enchill, AD, Salisbury, D., Date, K, Kim Mulholland, Gibani, Malick, Dougan, G +106 morecore +1 more sourceSummary of typhoid conjugate vaccine (TCV) coverage survey results among children 6 months to 15 years of age in Lyari Town, Karachi.
, 2023 Summary of typhoid conjugate vaccine (TCV) coverage survey results among children 6 months to 15 years of age in Lyari Town, Karachi.Sonia Qureshi (6940871), Rehana A. Salam (8098277), Tahira Sadaf (16792862), Zoya Haq (11140940), Mohammad Tahir Yousafzai (8982443), Farah Naz Qamar (6940889), Rabab Batool (16792856), Rafey Ali (16792859), Miqdad Ali (16792865) +8 morecore +1 more sourceTyphoid: From past to future
, 2019 Making a Difference? brings together medical humanities and sciences experts to analyze how historical and new data on typhoid control can be brought to bear on the current context of typhoid conjugate vaccine rollouts and extensively drug-resistant ...Kirchhelle, Claas, Vanderslott, Samantha, Vanderslott, S, Pollard, Andrew +3 morecore +1 more source
